Brain GABA Levels and Treatment Response in Major Depressive Disorder

Phase 4 Completed 40 enrolled Massachusetts General Hospital Mclean Hospital · collab

NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate changes in brain gamma-aminobutyric acid (GABA) levels due to treatment with escitalopram in people with major depressive disorder.

Timeline

Start: 2006-09
Primary completion: 2009-09
Completion: 2009-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Escitalopram	Small molecule	10 mg	Oral

Brain GABA Levels and Treatment Response in Major Depressive Disorder

Summary

Timeline

Drugs

Indications